The RCVS has announced that registrations for the new RCVS Register of Veterinary Practice Premises will be accepted from 1 November 2008, allowing all those who wish to supply medicines from veterinary practice premises from 1 April 2009 onwards a full five months to comply with the latest medicines legislation.
In order to fulfil its obligations under European law to maintain and improve traceability of, and accountability for, veterinary medicines, the UK Government decided that any veterinary surgeon may only supply veterinary medicinal products (VMPs) from premises registered with the Secretary of State, with effect from 1 April 2009.
The Veterinary Medicines Directorate (VMD) is responsible for the inspection and registration of practices under the Veterinary Medicines Regulations. Steve Dean, VMD's Chief Executive, says the new veterinary practice premises register will complete the UK information base by bringing veterinary practices in line with other suppliers of veterinary medicines who already have to operate from registered premises.
The Register will enable the supply of veterinary medicines by veterinary surgeons, including controlled drugs, to be subjected to inspection and verification. As a result, DEFRA Ministers and the European Commission can be re-assured that veterinary medicines are being supplied in the UK in accordance with EC legislation.
In discussion with the VMD, it was agreed that the most appropriate body to maintain this register would be the RCVS, not least because the College already manages the RCVS Practice Standards Scheme and publishes the (voluntary) Directory of Veterinary Practices, so has the necessary systems already in place. The register will be published on RCVSonline and updated quarterly.
Whilst there will now be a statutory fee levied for each practice premises registered on the new Register, the College's existing database framework has kept this to a relatively low £40 compared to what other bodies might have had to charge after starting from scratch.
Practices could appear in the Directory for free because the cost of producing it was partially covered by subsequent data sales. However, the new Register will need to be self-funding, as the data it contains will be freely available online.
Not all practices will have to pay the statutory fee. RCVS President Jill Nute said: "For those practice premises already accredited under the RCVS Practice Standards Scheme (PSS), the fee will be taken from their existing PSS annual fee.
"What's more, accredited practices will not face additional four-yearly inspections by VMD inspectors (unless there is an investigation for enforcement purposes) as their PSS inspections already ensure that they keep up to date with current medicines legislation."
Practice premises that have applied to join the Scheme, but have not yet been accredited, will not face additional VMD inspections either, but will still need to pay the statutory fee.
To help practices understand the new requirements and what they need to do before next April, the RCVS has produced a range of guidance, including a series of Frequently Asked Questions (www.rcvs.org.uk).
"In particular, we hope this guidance will help to explain which premises are likely to be considered ‘veterinary practice premises' and the difference between those premises and places where medicines might simply be stored or kept," said Mrs Nute.
"It is important to realise that there is a legal requirement to register veterinary practice premises for the supply of medicines, and a professional obligation, set out in the Guide to Professional Conduct, to keep a record of where all medicines are stored or kept. This record should avoid the need for additional registration of car boots, farms and homes."
Over the coming weeks, application forms will be posted to all practices currently listed in the Directory and accredited under the PSS, containing all the practice information currently held. These forms must be checked, signed and returned, even if no fee is due. Separate application forms will be available for any non-accredited practice premises not published in the Directory, and a letter will be sent to all RCVS members to ensure the whole profession is aware of the new requirements.
The review started with a series of focus groups amongst veterinary professionals across multiple sectors.
This was followed by an analysis of the information gleaned from the focus groups, additional stakeholder submissions, data from the College's Covid surveys, independent research studies and formal legal advice to formulate an online qualitative survey to gain the views and feedback of UK-based veterinary professionals.
In this final stage, the public consultation, all veterinary professionals, vet and vet nurse students, practice managers and all those who work in the veterinary practice team are invited to share the extent to which they agree (or disagree) with each element of the proposed new guidance on ‘under care’, their views on the requirements for a 24/7 follow-up service following a remote prescription and other safeguards, and their feedback on the proposed definition of limited-service providers.
There will also be a consultation with members of the animal-owning public, which will likely include questions asking for information about animal owner experiences with remote prescriptions, the perceived advantages and/or disadvantages of remote prescribing, and views on 24/7 care and how important a service this is to respondents.
Dr Melissa Donald MRCVS, RCVS President and former Chair of the Standards Committee, said: “The past two years have shown us that the veterinary professions are highly capable of adopting new ways of working.
"It also revealed that we can adapt our established ways of practice to better respond to shifts in public expectations and advancements in technology.
"However, it is our collective responsibility to ensure that any changes continue to allow us to provide safe and effective care for our patients, and meet the appropriate expectations of our clients.
“Whilst we recognise and reflect on the need for change, the proposed guidance seeks to protect animal health and welfare and maintain public trust by ensuring that decision-making remains firmly in the hands of individual veterinary surgeons, as to what they, in their professional judgement, consider appropriate in a specific situation.
“This consultation, then, while not a referendum on whether RCVS guidance on ‘under care’ and 24-hour emergency first-aid and pain relief should change – that decision having been made by Standards Committee and approved by Council based on the evidence gathered, including the views of the profession and objective evidence, and legal advice – is a crucial opportunity for veterinary colleagues to tell us whether we have got the draft guidance right, whether the proposed safeguards are sufficient, and whether there is anything we might have missed or should amend.”
www.rcvs.org.uk/undercare.
The RSPB has reported the results of two studies which revealed that a greater diversity of birds of prey, including some eagles, are killed eating carrion contaminated with diclofenac.
The RSPB says that these findings strengthen the case of banning the use of veterinary diclofenac in livestock across Europe, including Spain and Italy where the drug has already been approved.
In the first paper1, published in the journal Bird Conservation International, scientists present results of tests carried out on two steppe eagles found dead at a cattle carcass dump in Rajasthan, India. Both birds had diclofenac residue in their tissues and exhibited the same clinical signs of kidney failure as seen in Gyps vultures experimentally given diclofenac.
Steppe eagles are closely related to the golden eagles found in the UK, the vulnerable Spanish imperial eagle and other globally vulnerable or declining Eurasian eagles. Scientists now fear that all species in this genus, known as Aquila, are susceptible to diclofenac. With fourteen species of Aquila eagle distributed across Asia, Africa, Australia, Europe and North America, this means that diclofenac poisoning should now be considered largely a global problem.
Dr Toby Galligan, RSPB conservation scientist and one of the authors of the paper, said: "We have known for some time that diclofenac is toxic to Gyps vultures, including the Eurasian griffon vulture, but we now know it is toxic to an Aquila eagle too. This suggests that the drug is fatal to a greater number of birds of prey in Asia, Europe and around the world. We had suspected as much from observed declines in non-Gyps vultures in Asia, but this study confirms our worst fears."
In another paper2, published in Bird Conservation International, Dr Galligan led an examination of recent population trends in Egyptian and red-headed vultures in India. That study shows population declines of similar timing and scale as the declines observed in Gyps vultures, providing indirect evidence that these species have been impacted by diclofenac as well.
After years of campaigning by conservationists, the governments of Bangladesh, India, Nepal, and Pakistan banned veterinary formulations of diclofenac between 2006 and 2010. Recently, experts have recorded a slowing of Gyps vulture declines as a result of the bans. However, formulations of diclofenac intended for use in humans are still widely available and illegally used to treat livestock, the carcasses of which are the main food source for vultures in South Asia. It was announced in March that veterinary diclofenac had been authorised for manufacture and use in Italy and Spain and had been distributed to other European countries. Since then, a coalition of organisations including the Vulture Conservation Foundation, the RSPB and BirdLife International have been campaigning for this decision to be reversed.
Dr Galligan continued: "In light of recent developments in Europe, our findings take on an even more worrying meaning. All of Europe's charismatic Aquila eagles, like the Spanish imperial eagle and, closer to home, the golden eagle, are opportunistic scavengers and therefore could be at risk of diclofenac poisoning. As we have seen in South Asia, wherever free-ranging livestock are treated with diclofenac, population declines in vultures and eagles can occur. The European Commission needs to recognise this problem and impose a continent-wide ban on veterinary diclofenac before it can impact on our birds."
Last week, the Veterinary Medicines Directorate (VMD) announced measures against the drug.
In a statement the VMD said: "The UK's Veterinary Medicines Directorate is taking the issue of diclofenac's risks to vulture populations seriously. As a precautionary measure the VMD will not approve any requests from vets to import products containing diclofenac. Furthermore, the VMD has agreed not to issue any export certificates which name diclofenac-containing products in the list of products to be exported."
Sacha Cleminson, Head of International Biodiversity Policy at the RSPB, said: "The announcement from the Veterinary Medicines Directorate is a welcome signal to Europe that the UK is taking the issue seriously. This new evidence underlines the need for a ban across Europe, and ultimately beyond."
References
Have population declines in Egyptian Vulture and Red-headed Vulture in India slowed since the 2006 ban on veterinary diclofenac? Toby H. Galligan et al. Bird Conservation International Online. 1st April 2014.
This year the event delivered more than 90 hours of CPD lectures, workshops and practicals across six separate streams, over three days. Over 100 veterinary industry leaders showcased their wares in the commercial exhibition hall and there were a number of social events for delegates.
Delegates awarded the scientific programme an average score of 4.7 out of 5 stars, and 94% of delegates said they will put what they learnt into practice and use it in their day-to-day role. 94% also said Congress was good value for money.
Swissvet, a company which makes power dentistry equipment, won the Veterinary Practice Best New Exhibitor Award. CEO Dr Ruedi Steiger said: We have distributors throughout Europe, but it is the first time Swissvet has exhibited at BEVA. It has been a fantastic experience and I am thrilled to have won this award. I definitely plan to come back next year."
Next year’s BEVA Congress will be held in Birmingham from 9-12 September 2020. For further information visit www.beva.org.uk.
Photo: David Boughey
Focusing on the approach, diagnosis and treatment of regurgitation in dogs and cats, the webinar looks at how to differentiate regurgitation from vomiting and the way some diseases can cause inflammation, obstruction or dysmotility of the oesophagus, which can often result in regurgitation.
Aarti Kathrani graduated from the Royal Veterinary College (RVC) and is now a Senior Lecturer in Small Animal Internal Medicine, where she is involved with the clinical internal medicine service. She also helps provide nutritional input to clinical cases seen at the Queen Mother Hospital for Animals, where her research centres on canine and feline gastroenterology and nutrition.
Aarti said: “The webinar is designed to help general practitioners differentiate between regurgitation and vomiting, as well as provide a comprehensive review of the different causes of regurgitation and the diagnostic approach to this. Treatment is also discussed for this condition. We hope the webinar provides a useful guide to help diagnose and manage these cases in general practice.”
The regurgitation lecture is freely available and can be accessed via the Webinar Library here: https://www.bsavalibrary.com/content/webinar-library.
The lecture complements the BSAVA Manual of Canine and Feline Gastroenterology, which was published in 2019 to give readers a greater insight into the GI conditions they are treating. The Manual is divided into four main sections, focusing on; Diagnostic procedures and techniques; Diagnostic approaches to problems; Patient Management; Diseases of specific systems/organs.
The Manual costs £60.00 for BSAVA members; £90.00 for non-members and can be purchased from the BSAVA website here: https://www.bsava.com/Shop/Veterinary-books#!prod/f1a8220f-3ff7-e911-80e7-005056be4acd/curr/GBP
Sabrina joins Fran Taylor-Brown, Simon Bertram and head of service Tom Cardy.
Tom, a European and RCVS specialist in neurology, said Cave is now the biggest specialist-led neurology service in the South West:
“We are very pleased to have Sabrina join the neurology service at Cave, expanding our team to four European and RCVS-recognised specialists in veterinary neurology. This really sets Cave apart from our competitors.
“Sabrina’s arrival, in conjunction with the installation of our new state-of-the-art MRI scanner, means we can see most urgent neurology referrals within 24-48 hours in nearly all cases and increase the number of neurology cases we treat each day.”
Cave’s new £1.2m Phillips Ingenia 1.5T Evolution offers 50% faster scans at a far higher resolution than its previous MRI and shorter general anaesthetics for patients.
It also allows a more detailed and accurate diagnosis of complex neurological conditions.
Tom added: “The MRI scanner is one of the most advanced imaging modalities for the nervous system, providing millimetre-thick cross-sectional images of the brain and spinal cord which is essential for both accurate diagnosis and treatment.
“Having such advanced equipment and facilities plus four recognised specialists means all our clients and their pets will see a vet with the highest level of training in veterinary neurology.
“All of our specialists are happy to discuss challenging cases on the phone with our referring vets and Sabrina's skills and enthusiasm will continue to improve and diversify the service we offer.
https://cave-vet-specialists.co.uk
Further investigation revealed that the products in question: AVA Mature Cat Chicken 2kg, AVA Mature Cat Chicken 4kg, AVA Senior Cat Chicken 2kg and AVA Adult Cat Neutered Indoor 1.5kg, all had insufficient levels of thiamine (vitamin B1), which caused the cats to exhibit symptoms of sudden collapse, fitting, widespread twitching and general unsteadiness.
Talking to the BBC, Pets at Home spokesperson Brian Hudspith said it was important to alert veterinary surgeons as well as customers because thiamine deficient cats would usually present with quite different symptoms, including stiff limbs and the head falling onto the sternum.
He said: "Rather than the more typical cervical ventroflexion (head falling onto the chest) associated with thiamine deficiency, in the three cases we saw the predominant clinical signs included sudden collapse, fitting, widespread twitching and general unsteadiness on their legs, which began suddenly after 4-6 weeks of being on the diet."
Pet owners who have bought the products are being advised by the company to dispose of the contents and return the packaging to any Pets at Home store for a full refund. Owners who think their cat is demonstrating any of the symptoms are being advised to seek immediate veterinary advice, and to contact the company's customer advisors on 0800 328 4204.
IMPORTANT UPDATEDavies Veterinary Specialists has published advice and support for veterinary professionals and pet owners concerning the diagnosis and treatment of thiamine deficiency in cats, here.
In response to the question ‘How important is sustainability to you personally?’, 57% of respondents said it was very important making it the most popular choice.
However, in answer to the question: ‘Is your practice team actively working to improve sustainability?’, 20% of respondents said ‘Always/wherever possible’ and 42% said ‘Most of the time’, leaving 38% not actively working to improve sustainability.
IVC says the conclusion to be drawn is that sustainability is a personal priority, but this isn’t always translating to practice and more can be done.
To help with this, the company will shortly Positive Hoofprint, an Equine and Farm specific toolkit to help practices become more sustainable, with resources, checklists and practical advice for prioritising environmentally friendly initiatives.
Mark Tabachnik, UK Head of Equine for IVC Evidensia, said: “It’s clear from our survey that sustainability is still being treated as a secondary concern in practice, and this is something that IVC Evidensia is actively seeking to change.
“With our Positive Hoofprint about to be launched, there has never been a better time to prioritise our sustainability goals and to embed them in our own practices.
“This will give colleagues the tools they need to care for the planet, so we can fundamentally change equine veterinary to be more environmentally conscious for the future.”
The Royal College of Veterinary Surgeons is seeking feedback on a new draft Code of Professional Conduct for Veterinary Nurses.
The new draft Code, which would replace the existing RCVS Guide to Professional Conduct for Veterinary Nurses, has been produced by a Working Party set up by the RCVS Advisory Committee to review the Guides for both veterinary surgeons and veterinary nurses.
It is the benchmark for professional conduct against which registered veterinary nurses will be measured in any hearings on serious professional misconduct held by the recently-introduced VN Disciplinary Committee.
The purpose of the review is to ensure that guidance to the profession, and the public, is clear, for example, using consistent language to distinguish between what must be done and what is advised.
The new Code is a short, principles-based document, using the Federation of Veterinarians of Europe's Code of Conduct as the starting point. It will be supported by additional advice on specific areas of veterinary practice or issues, for example, clinical governance.
The consultation follows an earlier one for a new draft Code for veterinary surgeons that closed at the end of June: the new Code for veterinary nurses follows the format and style of that for veterinary surgeons. Comments made during the veterinary surgeon consultation will be taken account of alongside comments made during this new consultation.
For the first time, the draft proposes that veterinary nurses make a declaration on joining the VN Register, which underlines the primary importance of animal health and welfare: "I PROMISE AND SOLEMNLY DECLARE that my constant endeavour will be to ensure the welfare of animals committed to my care and that I will pursue the work of my profession with integrity and accept my responsibilities to my clients, the public, the profession and the Royal College of Veterinary Surgeons."
Comments on the proposed draft are invited from the veterinary nursing profession, the veterinary profession and the public, particularly on the issue of whether the Codes for veterinary nurses and veterinary surgeons ought to be combined.
Andrea Jeffery, the RCVS Veterinary Nurses Council member who led the group tasked with developing the new Code, said: "It is 50 years since the start of the veterinary nursing profession and the changes proposed in the Code reflect the development of our professional role over this time.
"This new Code is a simplified document that focuses on key principles and which will be supported by more detailed guidance. Although it follows the format of the draft Code for veterinary surgeons, it is important that we recognise our unique position as veterinary nurses."
The new Code, together with the consultation paper, can be downloaded at www.rcvs.org.uk/VNcodeconsultation.
Comments should be sent by email to Christopher Murdoch, Secretary to the Guides Review Working Party, at c.murdoch@rcvs.org.uk by Friday, 21 October 2011.
Pfizer Animal Health's Equine Herpes Virus (EHV) vaccine (Duvaxyn EHV 1,4) has been rebranded Equip EHV 1,4).
Pfizer says that EHV is carried by most horses in the UK1 and can cause respiratory disease, abortion and more rarely neurological disease. However, it is the more common sub-clinical infections that pose the most apparent issue for the competition client, with the associated loss of performance and the potential effect on the health of the whole yard.
Once infected with EHV, a horse can harbour the virus throughout its life and potentially shed the disease to other animals without showing any outward signs. According to the company, vaccinating helps to minimise the severity of the disease itself and importantly, can also help to reduce the amount of infective virus that is shed to other in-contact horses.
Equip EHV 1,4 is given as a primary course of two vaccinations, 4-6 weeks apart followed by a single dose every six months. It can also be used as an aid in the control of EHV-1 abortion - pregnant mares should be vaccinated with a single dose during each of the 5th, 7th and 9th months of pregnancy.
For further information on Pfizer's EHV campaign, to obtain literature for your practice or to book a talk for your clients contact your Pfizer Account Manager or Pfizer Animal Health, Walton Oaks, Tadworth, Surrey KT20 7NS.
Reference
1. Eddington et al. Equine Vet. J. 1994; 26 (2): 140-142.
The course was developed with RCVS Leadership and Inclusion Manager, Gurpreet Gill (pictured), and aims to increase self-awareness of unconscious bias, explore strategies to reduce it, and promote equity, diversity, and inclusion in the workplace.
Gurpreet said: “Unconscious bias is an area that some within the professions may not be familiar with and so this course provides an overview of unconscious bias and its impact in the workplace.
“We also explore strategies that we can all apply to help reduce unconscious bias.
"This is important in helping to achieve fairer and more equitable working environments, and I’d encourage any veterinary professional, whatever your role, to undertake the course.”
The course is accessible free via the RCVS Academy, and takes about an hour and three quarters to complete,
Building on the unconscious bias course, the RCVSA academy has also launched a course for members of the Fellowship Credentials Panels, who are responsible for assessing applications to the Fellowship.
Dr Niall Connell FRCVS, Acting Chair of the Fellowship Board, the governing body for the learned society, said: “This course explores the complexities of assessing applications, ensuring that each candidate receives a fair and thorough evaluation.
"Participants will gain insights into best practices for reviewing applications, offering constructive feedback, and identifying and addressing potential biases that may influence decision-making.
"By completing this course, participants will gain a heightened proficiency in assessing applications and managing bias, enabling them to support the RCVS’ mission of fostering equity, diversity and inclusion within the Fellowship.”
https://academy.rcvs.org.uk
Vetoquinol UK Ltd is launching a dedicated large animal/equine sales force on the 1st July.
The company says the move reflects the change in cattle and equine veterinary practice to become specialists.
Vetoquinol's large animal brands include: Marbocyl®, Sedalin®, Equistro®, Tolfine®, Pro Rumen and Locatim®.
The new team comprises:
The new sales team will be managed jointly by Hugh Gibson and Stuart Wade.
For further information or to make an appointment please contact your local Territory Manager direct or telephone 01280 825424
The company has also carried out research amongst 60 practices which found that despite the fact that over 80% of dogs over the age of three reportedly suffer from dental disease1, only 48% opened discussions about dental care at the earliest opportunity: vaccination time. 16% only discussed dental care if the dog developed a dental problem and 52% also admitted that they did not follow up discussions on dental compliance.²
Eleanor Workman Wright, Product Manager at Animalcare, said: "The key to successful dental care is to start early, both in educating owners and getting puppies and kittens used to brushing or other forms of dental care. If discussions are delayed until the animal is a year old, it is possible that some disease may already be present while the animal may be less receptive to brushing or other efforts to care for their teeth.
"We see the dental sector as important and one that is likely to grow, particularly in the light of the pandemic-induced increase in the number of dogs and cats. We hope that our new Owner Guide will support veterinary teams in initiating early discussions with owners about the importance of dental care, while the addition of an affordable and effective oral gel in Orozyme, to our range will give them a key tool to offer to owners to use as part of their homecare routine."
For more information, contact your Animalcare Territory Manager or visit: www.animalcare.co.uk .
The package includes pre-built templates, dedicated support during implementation, comprehensive training and 6 months’ free access from go-live to the cloud-based platform.
The company says it is launching this service after seeing the number of start-up practices reaching almost pre-pandemic levels according to Companies House data.
Scott Goodsir-Smyth, General Manager for the UK and Ireland at Provet Cloud said: "A progressive practice management system is essential for the smooth running of a modern veterinary practice, however selection and implementation can be stressful, particularly for start-ups when there are so many other important decisions to make.
"We have streamlined our implementation process and incorporated a number of out-of-the-box templates, pre-built wholesaler price lists and laboratory panels to speed up configuration and take the strain off our customers.
"We also understand that cash-flow is a major concern during ramp-up, so we are delighted to be able to offer start-ups in our region 6 months’ free access to the system, whilst they open and establish their practice’.
Training and support is provided by the UK Provet Cloud team, made up of qualified vets, nurses and practice managers.
Danny McClelland, implementation lead at Provet Cloud UK and Ireland, said: "We made a conscious decision to employ people with clinical or hands-on experience in practice for our implementation, training and support roles."
https://www.provet.cloud/veterinary-start-up-software
The case came after the NHS issued new guidelines for Clinical Commissioning Groups (CCG) in November 2017 which listed homeopathy alongside herbal medicine and glucosamine/chondroitin as treatments which should not now be prescribed to new patients and which CCGs should assist in de-prescribing in all patients, on the grounds that they are "products of low clinical effectiveness, where there is a lack of robust evidence of clinical effectiveness or there are significant safety concerns."
The British Homeopathic Association challenged the decision on the grounds that the public consultation which preceded the guidelines was, amongst other things, conducted unfairly and biased/predetermined.
The judge, however, ruled otherwise, saying in his ruling that the consultation was "fair and balanced" and there was "no evidence of bias or predetermination on NHSE's part".
NHS chief Simon Stevens welcomed the decision, saying: "There is no robust evidence to support homeopathy which is at best a placebo and a misuse of scarce NHS funds.
"So we strongly welcome the High Court’s clear cut decision to kick out this costly and spurious legal challenge."
Photo: Multicolored homeopathy tubes isolated on a white background. Lush. Shutterstock.
The oral corticosteroid powder formulation was previously only available in 180g tubs.
Severe equine asthma, which was previously known as Recurrent Airway Obstruction (RAO), Chronic Obstructive Pulmonary Disease (COPD) or Heaves, can lead to airway neutrophil influx and excessive mucus production. Although it is generally managed by environmental measures to suppose triggering factors, it can be combined with corticosteroid therapy to control airway inflammation in more severe cases.
Alana McGlade BVMedSci BVM BVS MRCVS, Equine Business Manager, said: "Severe equine asthma is the most common cause of chronic coughing in mature horses. Attributed to a hypersensitivity to inhaled allergens and dust, clinical signs - such as inflammation of the airways - can be alleviated by Equisolon’s active ingredient prednisolone.
"Prednisolone has been shown to have positive effects on clinical signs, endoscopic evaluation, arterial blood gases and pulmonary function when used in conjunction with environmental changes to reduce a horse’s exposure to potential triggers.
"Previously, vets would have had to measure out the powder but the sachets make dosing more convenient. The sachets come in a box of 10, so each pack will treat one 300 kg horse for 10 days or one 600 kg horse for 5 days. As the sachets are pre-measured, horses get exactly the dose they need.”
Equisolon oral powder contains 33.3 mg/g of prednisolone and should be administered at 1 mg prednisolone per kg of body weight per day. Treatment can be repeated at 24 hour intervals during 10 consecutive days.
For more information visit www.dechra.co.uk
Having experienced the profession both as a clinician and as a director, Clive says he wanted to develop and integrate his skills to support fellow professionals. So, during lockdown, he embarked on a Master’s in Executive Coaching from Ashridge Hult Business School.
Clive said: "Studying for the Master’s was intellectually and emotionally tough. The emphasis was on psychology and relationships, working to the highest standards of ethical coaching practice. It has not only developed my coaching skills but also afforded me the opportunity to scrutinise the drivers and motivations behind my career choices and integrate them into a wider appreciation of life and my ‘self’. I am incredibly proud of this achievement and conscious of the privilege afforded me."
Clive's service typically involves six ninety-minute sessions during which he'll help you develop skills, behaviours and ways of behaving that will make you a better leader, particularly if you come from a clinical background where you'd be used to using very different skillset.
Clive, who is also a European Mentoring and Coaching Council Senior Practitioner, added: "In my practice as a coach, I am grateful for the opportunity to support others, whatever their life experiences, as they negotiate the challenges of being themselves, in the workplace, serving their communities.”
For more information, visit: www.trelliscoaching.co.uk
The guidelines, which are the result of a collaboration between veterinary dermatologists, clinical microbiologists and other specialists, are designed to reduce inappropriate antimicrobial use and help canine welfare.
The team conducted an evidence review and built a consensus of recommendations, combining scientific evidence with real-world insights.
The new guidelines are supported by the ISCAID (International Society for Companion Animal Infections) and provide veterinary practitioners with guidance on the diagnosis and investigation of canine bacterial skin infections.
The guidelines offer recommendations for when antimicrobials should be considered, and which classes of antimicrobials are most appropriate to choose from.
As part of this guidance, recommended drug dosages have also been updated based on newly available information.
The RVC says this will ensure that available antimicrobial drugs can be used as responsibly as possible and remain effective for a long as possible.
RVC has also produced a short synopsis of the main consensus statements and a ‘Seven Moments of Responsible Canine Pyoderma Treatment’ infographic.
Anette Loeffler, Professor in Veterinary Dermatology and Cutaneous Bacteriology at the RVC and chair of the ISCAID author group, said: “After several years of analysing evidence, updating information and evaluating experience, we are excited and relieved to finally see the guideline documents published and free to use around the world.”
https://pubmed.ncbi.nlm.nih.gov/40338805
Improve International has launched a new course for veterinary receptionists to achieve the nationally accredited Edexcel QCF Level 2 Certificate in Customer Service, but with the assessment tailored specifically to demonstrate excellence in veterinary client care.
Veterinary receptionists may be able to benefit from government funding to enable them to study for the qualification, which Improve says can be delivered either at its HQ in Swindon or in practice.
Government funding is available for students of the Certificate in Customer Service without an existing Level 2 qualification in another subject. Requests also depend on the age of the learner and will be assessed on an individual basis by Improve's local Edexcel accredited centre in Swindon.
The 30 hour course features three core units, assessed by a one hour online test:
David Babington MRCVS, founder of Improve International said: "A successful veterinary practice is no longer just about a 'good' vet or nurse. It's about a practice team pulling together and playing their role to the top of their ability. The key role played by receptionists in terms of creating that vital first impression and helping to maintain client loyalty cannot be understated and we wanted to offer them a form of training that would help them develop their skills while achieving a nationally recognised qualification. We look forward to welcoming our first students later this year."
For further information or to register, email enquiries@improve-international.com; visit www.improvecpd.com or call 01793 759159.
The company says that by encouraging socialisation, natural behaviour and good health practices, the campaign will help puppy owners get their journey off to a good start and, with their vet, raise a dog that is healthy and family friendly.
The initiative comprises a range of practice materials, including health advice, training and behaviour tips, and a new owner video covering the essentials of puppy ownership.
The materials include digital content to use in email campaigns and on practice websites and social media channels.
Further support on how to optimise social media channels is also available to practices through PetNatter – Boehringer's free veterinary resource designed to help practices make the most of the opportunities social media provides.
Evelyn Murphy, senior brand manager for NexGard Spectra, said: “The ‘Relax, it’s a Puppy Thing’ initiative is a breath of fresh air and will provide puppy owners with just what they need to help them nurture a puppy through its formative life-stage, while easily and effectively supporting practices in communicating with owners on puppy health and welfare.”
For further information, contact your Boehringer Ingelheim territory manager.
The plenary speaker was Professor Rory O’Connor, Chair of Health Psychology at the University of Glasgow’s Institute of Health & Wellbeing whose talk: "When it is darkest: understanding suicide risk" opened the day with an outline of his 25 years of work looking into suicide prevention.
Rory discussed his recent investigation into the impact of the Covid-19 pandemic on people’s mental health and wellbeing, and how to reduce the risk of suicidal ideation turning into suicidal action.
He said: “In the last 10 to 15 years there has been an increased focus in particular on psychological and psycho-social interventions for helping people who are suicidal.
"Although suicide is complex, interventions, even brief interventions, can be effective.”
Rory was followed by presentations from a number of teams, including those who'd been awarded the MMI’s Sarah Brown Mental Health Research Grant in 2019 and 2020:
The full report of the day’s talks can be found here https://www.vetmindmatters.org/resources/report-mind-matters-initiative-research-symposium-2021
Nurtured Pets has launched the Anti-Lick Strip PreventTM, ProTM and Pro CTM, billed as an alternative to the clumsy and uncomfortable e-collar.
The Anti-Lick Strips deter animals from licking, biting or chewing of hot spots, granulomas and surgical sites. According to the company, they are also an effective deterrent to prevent such behaviours brought on by anxiety, boredom or even insect bites.
Hayley Booth, product manager at Nutured Pets said: "The UK pet market has been crying out for products like these for years. The unique bandages have medical grade adhesive on one side and all-natural active ingredients on the other. The combination of cayenne pepper, lemon powder, clove oil and oregano delivers a natural deterrent to the animal's nose and tongue to prevent it from interfering with the affected area.
"The Pro and Pro C are made exclusively for vets; the Pro can be used for direct application onto the pet's fur, ideal for securing IVs or catheters, the Pro C has a stronger adhesive and is ideal for over-wrapping gauze and cast materials.
"The Prevent then provides a profitable over the counter version for take home use. The preventative nature of these pet plasters may help promote healing and lessons the chance of infection, inflammation or re-opened wounds. In clinical trials, pets avoided the Anti-Lick Strip over 90% of the time proving these unique bandage strips really do work.
"The innovative features and benefits of the products themselves combined with extensive retail marketing support and highly visible point of sale display materials mean they're a must have for every vet practice."
For more information or a product sample, visit www.nurturedpets.co.uk or call 02476 302 222.
CEVA Animal Health has launched the anti-inflammatory Meloxidyl for cattle and pigs.
Meloxidyl is meloxicam-based solution for the management of respiratory disease, mastitis and diarrhoea in cattle and non-infectious locomotor disorders and puerperal septicaemia and toxaemia in pigs. It is given via a single injection, when used in combination with suitable anti-infectives.
According to the company, Meloxidyl's one shot protocol means it is quick and economical to use; it allows control of inflammation and endotoxins and reduces somatic cell count, recovery time and risk of culling after clinical mastitis; it reduces the economical impact of respiratory signs in comparison with flunixin-based products and reduces the major clinical signs caused by toxins in cases of neonatal diarrhoea.
Meloxidyl can be used in combination with the company's range of anti-infectives, which includes Marbokem, Cevaxel and Florkem.
For further product information contact CEVA Animal Health Ltd, 90 The Broadway, Chesham, Bucks, HP5 1EG, telephone 01494 781510 or visit the website at http://www.ceva.uk.com/
The voluntary scheme, which has been welcomed by Farming Minister George Eustice and Welsh Government Cabinet Secretary for Environment and Rural Affairs Lesley Griffiths, improves a herd’s ‘score’ every year it is free from a bTB breakdown, awarding a status of 0-10.
This new bTB scheme will require the herd vet and cattle owner to work together on following a number of biosecurity measures already successfully implemented in five other cattle disease control programmes.
As well as reducing risk of infection, the country-wide programme could present informed purchasing opportunities. In particular, it could benefit farmers selling cattle from regions with a high risk of the disease or who wish to minimise exposure from bought-in animals. It could also give recognition for a farmer’s efforts to complement Government and industry strategies to control infection.
Farming Minister George Eustice (pictured left above, with BCVA President Andrew Cobner) said: "Dealing with Bovine TB is costing us £100 million a year and causing devastation and distress for farmers and rural communities across the country. 33,000 cattle were slaughtered because of the disease last year alone and many farms are subject to movement restrictions which can affect their trade.
"But we know some 40% of herds in the high-risk area in England have never had a breakdown, and the CHeCS scheme will help them to communicate this so they can carry out risk-based trading to support their businesses.
"The scheme will also recognise those practicing good biosecurity, which is a core part of our long-term plan to tackle bovine TB."
The scheme complements the Government’s 25-year plan to eradicate Bovine TB in England, and will provide another tool for farmers who want to show they are following best practice. It follows the launch of the TB Hub (www.tbhub.co.uk), which offers practical advice and guidance as well as background into the disease.
The Cabinet Secretary, Mrs Griffiths, said: "The Welsh Government has been supportive of this initiative from the start. By focusing on individual herds, the scheme complements our proposed regional approach, for example those herds in the high TB areas which have not recently had TB will be able to demonstrate they are a lower risk.
"This industry-led initiative aimed at reducing TB is to be welcomed and fits in with our principles of working in partnership and promoting the benefits of disease prevention. I urge Welsh farmers to engage with the scheme and reduce the risk of disease being introduced into their herd."
Across Great Britain, CHeCS has over 14,000 member herds, representing around 14% of cattle holdings in some form of monitoring, control and eradication of disease.
Keith Cutler, CHeCS board member and partner in the Endell Veterinary Group, said: "CHeCS so far has focused on control of non-statutory diseases – Johne’s Disease, IBR, BVD, Leptospirosis and Neospora. Participating health schemes have been monitoring the health status of participating herds for some years.
"With this programme, we will be working with Government to receive official TB test data with the agreement of the farmer. It’s an exciting development for CHeCS, but there is a natural fit because of the expertise CHeCS-accredited health schemes already have with monitoring biosecurity measures on their members’ farms."
Andrew Cobner, president of the British Cattle Veterinary Association, who has been technical lead on the project since the start, said: "All too often we are confronted with the view that there is little or nothing that we can do to control TB. We wouldn’t accept this attitude with any other infectious disease so it’s time farmers and vets fought back. We have a government that is willing to embrace all of the measures necessary and we have a 25 year plan in place. Part of this will involve increasing biosecurity and risk-based trading, and CHeCS is leading the way."
The CHeCS bTb Herd Accreditation scores run from 0 (following all CHeCS measures but had a herd breakdown within the past 12 months), to 1 (following CHeCS measures and one year since the last herd breakdown) all the way though to 10 (following CHeCS measures and 10 years or more since the last herd breakdown).
Veterinary surgeons who think their clients might want to know more can point them in the direction of: www.checs.co.uk to read the technical standard, programme handbook and Q&A. If it sounds advantageous to their farm, they should discuss joining with you, then contact one of the participating CHeCS-accredited health schemes listed on the website. The application form includes a privacy agreement to allow the Animal and Plant Health Agency (APHA) to send test data automatically to the health scheme, and a declaration from the herd vet. After the form is sent back, a starting score will be awarded.
More information on bTB is also available at www.tbhub.co.uk.
The webinar was hosted by RCVS Senior Vice-President Dr Melissa Donald, with Standards Committee Chair and Junior Vice-President Linda Belton, Registrar Eleanor Ferguson, and Head of Standards Gemma Kingswell.
The panel gave an overview of the main changes for the guidance, which comes into effect on 1st September, the considerations to take into account when prescribing POM-Vs remotely, the circumstances under which POM-Vs cannot be prescribed remotely, the prescription of antibiotics, antifungals, antiparasitics, and antivirals, and how the guidance will be enforced.
The webinar also dealt with issues raised in a previous webinar, including a query about prescribing under the cascade and an update on the position when prescribing based on cultures and sensitivities.
https://www.youtube.com/watch?v=vSTZKdbVD8g
For further information about the new guidance, including a range of practice-based scenarios and FAQs, visit: https://www.rcvs.org.uk/setting-standards/advice-and-guidance/under-care-new-guidance/
Questions about the under care guidance can be sent to advice@rcvs.org.uk